Health insurer Humana Inc. is alleging that medical-device maker Medtronic Inc. violated the federal racketeering statute by conspiring with prominent physicians to promote unapproved uses of its bone-growth drug, according to a lawsuit Humana filed in federal court last week. . Humana alleges that Medtronic paid $210 million to prominent physicians who advocated the drug's use in certain neck and spine surgeries that hadn't been approved by the U.S. Food and Drug Administration, according to Humana's complaint. Humana alleges...
  